Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
Donken R, Dobson SRM, Marty KD, Cook D, Sauvageau C, Gilca V, Dionne M, McNeil S, Krajden M, Money D, Kellner J, Scheifele DW, Kollmann T, Bettinger JA, Liu S, Singer J, Naus M, Sadarangani M, Ogilvie GS.
Donken R, et al. Among authors: sadarangani m.
Clin Infect Dis. 2020 Aug 14;71(4):1022-1029. doi: 10.1093/cid/ciz887.
Clin Infect Dis. 2020.
PMID: 31617568
Free PMC article.
Clinical Trial.